{
  "type": "hyp",
  "text": "\"\"\"In order to investigate the nature of the A6H mAb costimulus at the transcriptional level we have examined induction of the transcription factors OCT-1 AP-1s cognate viral enhancer in the U3 region of the 3 LTR or the erythroid-specific GATA-1 transcription factor gene.\"\" When this membrane-proximal enhancer is replaced with a binding site for the erythroid-specific transcription factor GATA-1 the erythroid-specific enhancer is defective in this mutant enhancer.\"\n",
  "self": {
    "NER": {
      "answers": [
        "OCT-1",
        "3"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What transcription factor is defective when replaced with a binding site?",
          "What is the U3 region of the LTR?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "order",
        "the nature",
        "the A6H mAb costimulus",
        "the transcriptional level",
        "we",
        "induction",
        "the transcription factors",
        "viral enhancer",
        "the U3 region",
        "the 3 LTR",
        "the erythroid-specific GATA-1 transcription factor gene",
        "this membrane-proximal enhancer",
        "a binding site",
        "the erythroid-specific transcription factor",
        "the erythroid-specific enhancer",
        "this mutant enhancer"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is defective when the membrane-proximal enhancer is replaced with a binding site",
          "What did the study examine to determine the costimulus of the A6H m",
          "What is the nature of the A6H mAb?",
          "Where is the A6H mAb costimulus investigated?",
          "What is defective when the membrane-proximal enhancer is replaced with a binding site",
          "What is the nature of the A6H mAb costimulus?",
          "What is defective when the membrane-proximal enhancer is replaced with a binding site",
          "What is defective when the OCT-1 AP-1s are replaced with a binding site",
          "Where is the OCT-1 AP-1s cognate viral enhancer located?",
          "What region of the U3 gene is defective when the OCT-1 AP-1s cogn",
          "What is the mAb costimulus mediated by?",
          "What is defective when the A6H mAb is replaced with a binding site?",
          "What is replaced in the A6H mAb?",
          "What is defective when the membrane-proximal enhancer is replaced with a binding site",
          "What is defective when the membrane-proximal enhancer is replaced with a binding site",
          "What is defective when the membrane-proximal enhancer is replaced with a binding site"
        ]
      }
    }
  },
  "asked": {
    "What region of the LTR is replaced by an enhancer of the erythroid-": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.42102348804473877,
        "ground_truth": {
          "3": {
            "bertscore": 0.6802688241004944,
            "f1": 0
          }
        }
      }
    },
    "What region of the genome is replaced by an enhancer of the erythroid-specific": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.37618696689605713,
        "ground_truth": {
          "LTR": {
            "bertscore": 0.6756168603897095,
            "f1": 0
          },
          "the 3 LTR": {
            "bertscore": 0.6464024782180786,
            "f1": 0
          }
        }
      }
    },
    "What group of scientists developed retroviral vectors?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0001176595687866211,
        "ground_truth": {
          "We": {
            "bertscore": 0.605411171913147,
            "f1": 0
          }
        }
      }
    },
    "What did the researchers develop?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.006501555442810059,
        "ground_truth": {
          "retroviral vectors": {
            "bertscore": 0.7190877795219421,
            "f1": 0
          }
        }
      }
    },
    "What is replaced in the U3 region of the 3 LTR?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "membrane-proximal enhancer",
        "answerability": 0.7021279335021973,
        "ground_truth": {
          "the constitutive viral enhancer": {
            "bertscore": 0.8085882663726807,
            "f1": 0.4
          }
        }
      }
    },
    "What region of the 3 LTR is replaced by an autoregulatory enhancer?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.05562049150466919,
        "ground_truth": {
          "the U3 region": {
            "bertscore": 0.6482598781585693,
            "f1": 0
          }
        }
      }
    },
    "What is the constitutive viral enhancer replaced by?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "a binding site for the erythroid-specific transcription factor GATA-1",
        "answerability": 0.6857767701148987,
        "ground_truth": {
          "an autoregulatory enhancer": {
            "bertscore": 0.7060987949371338,
            "f1": 0
          }
        }
      }
    },
    "What is replaced in retroviral vectors?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.020893990993499756,
        "ground_truth": {
          "the erythroid-specific GATA-1 transcription factor gene": {
            "bertscore": 0.5600289702415466,
            "f1": 0
          }
        }
      }
    }
  }
}